Vaccine equity in the United States. While speed of vaccine rollout is important, the equitable distribution of vaccines to communities hit hardest by the pandemic is fundamental to reducing nationwide suffering. The New York Times has gathered and processed data that evaluates how county vulnerability correlates with vaccination percentage. Unfortunately, the data shows that moreContinue reading “Vaccine Equity”
Category Archives: Explain That Data!
One dose for COVID+ people?
Today we’re looking at a published data set from last week that evaluated the similarities and differences between antibody titers after 1 and 2 doses of mRNA vaccine in both individuals who had had Covid prior (seroposotive) and those who had not (seronegative). It is a limited study, with only 110 individuals and very littleContinue reading “One dose for COVID+ people?”
Moderna Immunity – 6 months!
Moderna vaccine shows strong antibody persistence at 6 months! **Antibody persistence is likely much longer and is being continually monitored. This data was published at the 6 month mark so that’s as far as can be reported on!** I am hoping this is a new kind of post you’ll see more often where I takeContinue reading “Moderna Immunity – 6 months!”